Fulltext

Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq

Dujaili JA 1 , Sulaiman SA 2 , Hassali MA 3 , Awaisu A 4 , Blebil AQ 5 , Bredle JM 6

Affiliations 

  • 1 Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia. Electronic address: jumandujaili@yahoo.com
  • 2 Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia
  • 3 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia
  • 4 Clinical Pharmacy and Practice Section, College of Pharmacy, Qatar University, Doha, Qatar
  • 5 Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, UCSI University, Jalan Menara Gading, UCSI Heights, Kuala Lumpur, Malaysia
  • 6 FACIT.org, Elmhurst, Illinois, USA
Int J Infect Dis, 2015 Feb;31:4-8.
PMID: 25486011 DOI: 10.1016/j.ijid.2014.12.004

Abstract

To determine how tuberculosis (TB) treatment affects the health-related quality of life (HRQL) of patients with pulmonary TB and to identify the predictors of favourable TB treatment outcomes in Baghdad, Iraq.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications